Project Details:

Keata Pharma Inc. (Sydney, Nova Scotia) Project: Daffodil-derived Product for Treatment of Alzheimer’s disease Keata Pharma Inc. will focus on the development and commercialization of a daffodil-derived natural product that can be used in the treatment of Alzheimer’s disease. Project collaborators include the Nova Scotia Agricultural College, in Truro, and the National Research Council’s Institute of Nutri-Sciences and Health. This project, with total estimated costs of $4.2 million, will receive approximately $3.0 million from the Atlantic Innovation Fund over a three-year period.

Keata Pharma will execute this project in conjunction with ABVC

Web Link:

http://mediaroom.acoa-apeca.gc.ca/e/media/press/press.shtml?4265

Photo: Successful Nova Scotia AIF Recipients (ABVC CEO - Dr. Richard Ablett -Back Row Center) with ACOA Minister Honorable Peter MacKay 

http://mediaroom.acoa-apeca.gc.ca/mediaroom/photo/form/medium_CLF2.shtml?548